We review various prognostic and predictive factors and present examples to illustrate how these factors can be used to improve our understanding about selection of adjuvant treatments, re-evaluation of data from previous clinical trials and design of future studies.
This study was performed through a re-evaluation of data previously presented by Hänsel Petersson et al. [ 7] in which the study group was described in detail.
Currently available data do not support the combining of exposure levels of perfluoroalkane acids for risk assessment, although re-evaluation after additional data are available is recommended.
Re-evaluation of available data highlights the temporal variability of decision making and elicitation of behaviour within and between individuals, and that sensitivity (d′), a measure of the ability to detect a signal (e.g. hydraulic gradient), increases with signal strength and when multimodal stimuli are presented.
Against this background and based on a re-evaluation of all data recorded since the plant's commissioning the current status (October 2015) does not require any near-term injection measures.
Now that several hundred genome sequences are available, a re-evaluation of these data using robust phylogenetic and evolutionary methods is clearly warranted.
A re-evaluation of the data using a random effects analysis did not change the overall conclusion.
This finding prompts careful re-evaluation of research data, as it is reasonable that literature concerning C. intestinalis sensu Linnaeus refers to both cryptic species.
It is a method of assigning probabilities based on the current state of knowledge, allowing for subsequent re-evaluation as new data becomes available.
An independent re-evaluation of fracture data from the Phase III study was performed using the Fracture Risk Assessment Tool (FRAX®) algorithm developed by the World Health Organization to estimate 10-year fracture risk.
The Delegation of the Netherlands expressing the views within the European Union, presented a proposal to suspend the consideration of the adoption of the MRLs for BST pending the re-evaluation of scientific data by JECFA and the CCRVDF and the examination of the application of the "other legitimate factors" in relation to BST by the Committee on General Principles.
